PE42898A1 - NEW DERIVATIVES OF 2- (3H) -OXAZOLONA - Google Patents

NEW DERIVATIVES OF 2- (3H) -OXAZOLONA

Info

Publication number
PE42898A1
PE42898A1 PE1997000228A PE00022897A PE42898A1 PE 42898 A1 PE42898 A1 PE 42898A1 PE 1997000228 A PE1997000228 A PE 1997000228A PE 00022897 A PE00022897 A PE 00022897A PE 42898 A1 PE42898 A1 PE 42898A1
Authority
PE
Peru
Prior art keywords
formula
alkyl
compounds
refer
hydrogen
Prior art date
Application number
PE1997000228A
Other languages
Spanish (es)
Inventor
Duran Carles Puig
Noguera Ferran Pujol
Forner Dolors Fernandez
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8294266&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE42898(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of PE42898A1 publication Critical patent/PE42898A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: R1 ES DE PREFERENCIA METILO O NR4R5, EN DONDE R4 Y R5 SON HIDROGENO, ALQUILO O BENCILO; R2 ES 2-NAFTILO, FENILO OPCIONALMENTE SUSTITUIDO CON 1; 2 o 3 ATOMOS DE Cl o F, O ES ALQUILO HIDROXILO, ALCOXI O CF3; R3, R4 Y R5 SON DE PREFERENCIA HIDROGENO. TAMBIEN SE REFIEREN A LOS PROCEDIMIENTOS DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I), DOS DE LOS CUALES COMPRENDEN: (A) HACER REACCIONAR UN CARBAMATO DE FORMULA (V) EN DONDE R1a ES ALQUILO O NR4aR5a, EN DONDE R4a Y R5a ES ALQUILO O BENCILO, CON ACIDO ACETICO ANHIDRO; O (B) HACER REACCIONAR EL COMPUESTO DE FORMULA (I) EN DONDE R1 ES Cl, CON R4-NH-R5. LOS COMPUESTOS OBTENIDOS ACTUAN COMO INHIBIDORES SELECTIVOS DE LA CICLOOXIGENASA-2 (COX-2), SIENDO UTILES EN EL TRATAMIENTO DE LA INFLAMACION, DEL DOLOR, DE LA FIEBRE Y DEL ASMA, O PARA LA PREVENCION DEL CANCER COLORRECTALTHEY REFER TO COMPOUNDS OF FORMULA (I), WHERE: R1 IS OF PREFERENCE METHYL OR NR4R5, WHERE R4 AND R5 ARE HYDROGEN, ALKYL OR BENCIL; R2 IS 2-NAPHTHYL, PHENYL OPTIONALLY REPLACED WITH 1; 2 or 3 ATOMS OF Cl or F, OR IS ALKYL HYDROXYL, ALCOXY OR CF3; R3, R4 AND R5 ARE OF PREFERENCE HYDROGEN. THEY ALSO REFER TO THE PROCEDURES FOR THE PREPARATION OF FORMULA COMPOUNDS (I), TWO OF WHICH INCLUDE: (A) REACTION A FORMULA CARBAMATE (V) WHERE R1a IS ALKYL OR NR4aR5a, WHERE R4a AND R5A OR BENCILO, WITH ANHYDRO ACID ACID; OR (B) REACT THE COMPOUND OF FORMULA (I) WHERE R1 IS Cl, WITH R4-NH-R5. THE COMPOUNDS OBTAINED ACT AS SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2 (COX-2), BEING USEFUL IN THE TREATMENT OF INFLAMMATION, PAIN, FEVER AND ASTHMA, OR FOR THE PREVENTION OF COLORECTAL CANCER

PE1997000228A 1996-03-21 1997-03-21 NEW DERIVATIVES OF 2- (3H) -OXAZOLONA PE42898A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009600685A ES2125161B1 (en) 1996-03-21 1996-03-21 NEW DERIVATIVES OF 2- (3H) -OXAZOLONA.

Publications (1)

Publication Number Publication Date
PE42898A1 true PE42898A1 (en) 1998-08-12

Family

ID=8294266

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000228A PE42898A1 (en) 1996-03-21 1997-03-21 NEW DERIVATIVES OF 2- (3H) -OXAZOLONA

Country Status (30)

Country Link
US (1) US6869968B1 (en)
EP (1) EP0888316B1 (en)
JP (1) JP3810091B2 (en)
KR (1) KR100496395B1 (en)
CN (1) CN1110488C (en)
AR (1) AR006340A1 (en)
AT (1) ATE197294T1 (en)
AU (1) AU713811B2 (en)
BR (1) BR9708141A (en)
CA (1) CA2249420A1 (en)
CO (1) CO4780046A1 (en)
CZ (1) CZ294963B6 (en)
DE (1) DE69703437T2 (en)
DK (1) DK0888316T3 (en)
ES (2) ES2125161B1 (en)
GR (1) GR3035096T3 (en)
HK (1) HK1015371A1 (en)
ID (1) ID16778A (en)
IL (1) IL126206A (en)
NO (1) NO311761B1 (en)
NZ (1) NZ331901A (en)
PE (1) PE42898A1 (en)
PL (1) PL188722B1 (en)
PT (1) PT888316E (en)
RU (1) RU2194043C2 (en)
TW (1) TW426674B (en)
UA (1) UA52645C2 (en)
UY (1) UY24499A1 (en)
WO (1) WO1997034882A1 (en)
ZA (1) ZA972203B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125161B1 (en) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S NEW DERIVATIVES OF 2- (3H) -OXAZOLONA.
FR2753449B1 (en) * 1996-09-13 1998-12-04 Union Pharma Scient Appl NOVEL 3,4-DIARYLOXAZOLONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES
ES2131015B1 (en) * 1997-09-12 2000-03-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF 2- (3H) -OXAZOLONE, PROCEDURES FOR ITS PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS.
ES2154561B1 (en) * 1998-09-25 2001-12-01 Almirall Prodesfarma Sa DERIVATIVES OF 2-FENILPIRAN-4-ONA.
ES2168895A1 (en) * 1999-03-26 2002-06-16 Almirall Prodesfarma Sa 2-Phenylpyran-4-one derivatives as cyclooxygenase-2 (COX-2) inhibitors useful e.g. for treating pain, fever or inflammation, preventing colorectal cancer or neurodegenerative diseases
EP1246621A4 (en) 1999-12-23 2004-11-24 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JP2005535642A (en) 2002-06-28 2005-11-24 ニトロメッド インコーポレーティッド Nitrosated and / or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use containing oximes and / or hydrazones
ES2215474B1 (en) 2002-12-24 2005-12-16 J. URIACH & CIA S.A. NEW DERIVATIVES OF PHOSPHORAMIDE.
ES2213485B1 (en) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. DERIVATIVES OF 2-FENILPIRAN-4-ONA.
ATE342722T1 (en) 2003-05-07 2006-11-15 Osteologix As TREATMENT OF CARTILAGE/BONE DISEASES WITH WATER SOLUBLE STRONTIUM SALTS
CN1309717C (en) * 2003-06-03 2007-04-11 李小虎 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
CA2676413A1 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866182A (en) 1988-02-18 1989-09-12 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoyl and aroyl oxazolones
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
DE4435547A1 (en) 1994-10-05 1996-04-11 Bayer Ag Sulfonylaminocarbonyltriazolinone with substituents bonded via oxygen and sulfur
JP2636819B2 (en) 1994-12-20 1997-07-30 日本たばこ産業株式会社 Oxazole-based heterocyclic aromatic compounds
ES2125161B1 (en) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S NEW DERIVATIVES OF 2- (3H) -OXAZOLONA.
FR2753449B1 (en) * 1996-09-13 1998-12-04 Union Pharma Scient Appl NOVEL 3,4-DIARYLOXAZOLONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES

Also Published As

Publication number Publication date
TW426674B (en) 2001-03-21
RU2194043C2 (en) 2002-12-10
NO984325L (en) 1998-11-23
HK1015371A1 (en) 1999-10-15
CO4780046A1 (en) 1999-05-26
EP0888316B1 (en) 2000-11-02
DE69703437D1 (en) 2000-12-07
CZ294963B6 (en) 2005-04-13
MX9701944A (en) 1998-06-30
PL328915A1 (en) 1999-03-01
US6869968B1 (en) 2005-03-22
DE69703437T2 (en) 2001-03-08
NZ331901A (en) 1999-10-28
UA52645C2 (en) 2003-01-15
GR3035096T3 (en) 2001-03-30
JP3810091B2 (en) 2006-08-16
PL188722B1 (en) 2005-04-29
AR006340A1 (en) 1999-08-25
EP0888316A1 (en) 1999-01-07
ES2125161A1 (en) 1999-02-16
CZ297998A3 (en) 1999-02-17
IL126206A (en) 2001-06-14
ZA972203B (en) 1997-09-25
UY24499A1 (en) 1997-04-02
NO984325D0 (en) 1998-09-17
CN1218459A (en) 1999-06-02
ES2125161B1 (en) 1999-11-16
BR9708141A (en) 1999-07-27
AU2289397A (en) 1997-10-10
ES2151254T3 (en) 2000-12-16
NO311761B1 (en) 2002-01-21
ATE197294T1 (en) 2000-11-15
KR100496395B1 (en) 2005-09-27
IL126206A0 (en) 1999-05-09
ID16778A (en) 1997-11-13
DK0888316T3 (en) 2000-11-27
PT888316E (en) 2001-02-28
JP2000506876A (en) 2000-06-06
CA2249420A1 (en) 1997-09-25
CN1110488C (en) 2003-06-04
WO1997034882A1 (en) 1997-09-25
AU713811B2 (en) 1999-12-09
KR20000064727A (en) 2000-11-06

Similar Documents

Publication Publication Date Title
PE42898A1 (en) NEW DERIVATIVES OF 2- (3H) -OXAZOLONA
BR9916590A (en) Pyrimidine derivative, process for preparing a pyrimidine derivative, method for producing an anti-cancer effect in a warm-blooded animal, use of the pyrimidine derivative, and pharmaceutical composition
AR023777A1 (en) NEW COMPOUNDS
BR9916282A (en) Compound, use of a compound and method of treatment
CO5170529A1 (en) DERIVATIVES OF 5- (REPLACED PHENYL) -2-PIPERAZINIL-PIRIMIDIN- (3,5- BISTRIFLUORO-METIL-BENCIL) -METIL-AMIDA
AR007456A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED INDAZOL AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
PE20011177A1 (en) 5-ALKYLPYRIDE [2,3-d] PYRIMIDINES ARE INHIBITORS OF TYROSINE KINASES AND DEPENDING ON CYCLINE
ES487537A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW QUINAZOLINE DERIVATIVES.
EA200001224A1 (en) DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA
BR9908764A (en) Compound and its pharmaceutically acceptable salts or hydrolysable esters in vivo, use of these, process for preparing them, and pharmaceutical composition
PE20050012A1 (en) BENZOPYRANE COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITORS
ATE109787T1 (en) ANTHRACYCLINE ANALOGUES CONTAINING LATENT ALKYLATION SUBSTITUENTS.
ES541170A0 (en) PROCEDURE FOR THE PREPARATION OF PIRIDO-BENZOTIACINA DERIVATIVES
PE20030208A1 (en) INDIRUBIN DERIVATIVES CONTAINING SULFUR, THEIR PREPARATION AND USE
ES557664A0 (en) A PROCEDURE FOR THE SYNTHESIS OF IMIDAZOL DERIVATIVES.
FI964463A0 (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
AR023111A1 (en) USEFUL SULFONAMIDE DERIVATIVES AS ANTAGONISTS OF THE 5-HT7 RECEPTOR, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION THAT UNDERSTAND
DE69914803D1 (en) BENZOXAZOLE DERIVATIVES FOR USE AS INTEGRIN INHIBITORS
ATE56716T1 (en) 2,4-DIPHENYL-1,3-DIOXANES.
ES519153A0 (en) PROCEDURE FOR THE PREPARATION OF NEW BENZODIOXIN DERIVATIVES AND THEIR ACID ADDITIONAL SALTS.
PT1042326E (en) NEW ACRONICINE DERIVATIVES PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT982305E (en) The present invention relates to a process for the preparation of the compounds of the general formulas (I) and (II) to the pharmaceutically acceptable excipients.
AR004949A1 (en) DERIVATIVES OF BENZOIL-4-PIRAZOL, PROCEDURE TO OBTAIN THEM, CONTAINING HERBICIDAL COMPOSITIONS AND PROCEDURES FOR COMBATING UNDESIRABLE PLANTS.
AR248394A1 (en) Pyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
YU17999A (en) New pentaerythritol derivatives, their production and use and intermediates for their synthesis

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed